Could these vaccine stocks be prime additions to your portfolio today? The post Good Stocks To Buy Right Now? 4 Vaccine Stocks To Check Out appeared...
The U.S. Food and Drug Administration greenlit Merck's and Ridgeback Biotherapeutics' molnupiravir under Emergency Use Authorization for the treatment of mild to moderate Covid-19 infections in adults who are...
The U.S. Food and Drug Administration placed a clinical hold on Gilead Sciences’ use of injectable lenacapavir in borosilicate vials in all ongoing clinical studies for HIV...
Doctor Says He Was Fired For Trying To Treat COVID Patients With Ivermectin Authored by Jack Phillips via The Epoch Times, A Mississippi doctor said he was fired...
Dying COVID-19 Patient Recovers After Court Orders Hospital To Administer Ivermectin Authored by Matthew Vadum via The Epoch Times, An elderly COVID-19 patient has recovered after...
Escobar: Fauci As Darth Vader Of The COVID Wars Authored by Pepe Escobar via The Asia Times, Robert F Kennedy Jr’s The Real Anthony Fauci: Bill Gates,...
With all eyes on the pandemic once again, these biotech players could be gaining more exposure. The post 4 Top Biotech Stocks To Watch Now appeared...
Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help turn the tide of the pandemic.
Kathryn Corzo Kathryn Corzo — an oncology veteran and the program head behind Sanofi’s multiple myeloma monoclonal antibody isatuximab — is now in the C-suite. The...
The EMA’s human medicines committee has recommended approval of Roche’s Ronapreve and Celltrion’s Regkirona for use in COVID-19, The post COVID antibodies from Roche, Celltrion backed...
Substances found in algae, squid and fish all have potential antiviral properties.
Regeneron Shares Surge As Antibody Cocktail Cuts COVID Risk By 81.6% For the third time in about a month, another major pharmaceutical competitor has released a...
Merck & Co and Ridgeback’s oral antiviral molnupiravir has been approved in its first market – the UK The post UK first to authorise Merck/Ridgeback’s COVID...
Take two recently-approved immunotherapies for triple negative breast cancer (TNBC), put them together, and what do you get? The post Gilead tags Merck for first-line triple...
The EMA has started a rolling review of Merck & Co and Ridgeback Biotherapeutics’ much-anticipated oral antiviral molnupiravir The post EU starts review of Merck’s oral...
Europe's drug regulator started a real-time review of AstraZeneca's antibody-based Covid-19 therapy, the first protective shot other than vaccines against coronavirus.
Merck has submitted data to the U.S. Food and Drug Administration for Emergency Use Authorization (EUA) for the company's antiviral pill molnupiravir.
Merck & Co. Inc. (NYSE: MRK) announced that it had sought the Food and Drug Administration’s permission to use its investigational antiviral tablet in the treatment...
These health care stocks could be the booster for your portfolio right now. The post 4 Top Health Care Stocks To Watch After Merck’s COVID-19 Pill...
Merck & Co is on the brink of plugging a gap in the coronavirus treatment armamentarium after its The post Merck preps filings for oral COVID...
India's Ivermectin Blackout: The Secret Revealed Authored by Justus R, Hope via TheDesertReview.com, On May 7, 2021, during the peak of India's Delta Surge, The World...
The pharmaceutical industry is concentrated in the US and Europe, and the 10 biggest drug companies are located in those regions. Check out this pharmaceutical industry...
Fox Guarding The Henhouse? Yes, Indeed! Authored by Terry Paulding via AmericanThinker.com, The compulsion to find out whether the Wu Flu started in the Wuhan lab,...
Pfizer Submits Vaccine Trial Data For Kids As Young As 5; Sanofi Abandons Development Of mRNA Jab Yesterday while receiving his Pfizer booster jab during a...
Pfizer Launches Final Study For COVID Drug That's Suspiciously Similar To 'Horse Paste' Another piece US anti-Ivermectin puzzle may have emerged. On Monday, Pfizer announced that...
A protein called CD47 that helps damaged cells avoid destruction by the immune system may be contributing to severe cases of Covid-19, researchers believe. In another...
Pfizer Inc. started a large study testing the company's investigational oral antiviral drug for the prevention of Covid-19 infection among those who have been exposed to...
Gilead Study Shows Remdesivir Reduced Risk Of Hospitalization When Given To COVID-19 Patients Early Authored by Zachary Stieber via The Epoch Times (emphasis ours), The antiviral...
Pfizer and BioNTech will sell 500 million doses of their Comirnaty Covid-19 vaccine to the US at cost as part of an expanded agreement to drive...
Medications to treat COVID-19 are in no way a substitute for the vaccine. But under the right circumstances, some show great promise for helping patients.